STTCOMP NRT, TA LONG Bio-pharmaceutical company using...

  1. ST
    3,037 Posts.
    STTCOMP NRT, TA LONG

    Bio-pharmaceutical company using breakthrough technology to create the CS-6 family of drugs to selectively kill cancer stem cells, without side effects

    Market Cap $49.5m Cash $33.3m

    Today we saw a break of the trading range. Volume not excessive, accompanied by a healthy spread and finishing the day on it's high.

    NRT3.jpg
 
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.